Today: 30 April 2026
AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

NEW YORK, December 30, 2025, 13:31 ET — Regular session

  • Nvidia was little changed after a report said it is in advanced talks to buy Israel’s AI21 Labs for up to $3 billion.
  • Meta rose after saying it would acquire AI startup Manus, with a source valuing the deal at $2 billion to $3 billion.
  • Investors are watching the Federal Reserve’s meeting minutes due at 2 p.m. ET for clues on the 2026 rate path.

Nvidia shares were nearly flat on Tuesday after an Israeli report said the AI-chip leader is in advanced talks to buy startup AI21 Labs for as much as $3 billion. Nvidia was down about 0.02% at $188.18 in early afternoon trade.

The M&A chatter is landing in a holiday-thin week when investors are reassessing crowded AI trades after a late-2025 tech rally stalled on Monday. Strategists say the rotation has looked more like year-end rebalancing than panic selling.

Traders are also bracing for macro headlines that can swing high-growth tech valuations, with minutes from the Fed’s December policy meeting due later Tuesday. High-multiple “AI stocks” tend to move with rate expectations because lower rates increase the present value of future earnings. Reuters+1

Calcalist reported Nvidia’s discussions with AI21 have advanced in recent weeks and put the potential price tag at $2 billion to $3 billion. Nvidia declined to comment and AI21 was not immediately available to comment, Reuters reported.

AI21, founded in 2017 by Mobileye founder and CEO Amnon Shashua and others, was valued at $1.4 billion in a 2023 funding round that included Nvidia and Alphabet’s Google, Reuters said. Calcalist said Nvidia’s interest appears focused on AI21’s roughly 200-person workforce.

Meta was among the brighter spots in AI-linked megacaps. Its shares rose about 1.17% to $666.40 after the Facebook owner said it would acquire Manus, a Singapore-based startup with Chinese roots, as it pushes into “agentic AI” — software that can take actions for users rather than only answering prompts. Reuters

A source with direct knowledge valued Manus at $2 billion to $3 billion, while Meta said it would integrate the service across consumer and business products, including Meta AI. “We see a natural fit into Meta’s fast-growing WhatsApp SMB footprint,” Rosenblatt Securities analyst Barton Crockett wrote, referring to small and medium-sized businesses. Reuters

Other AI bellwethers were mixed. Microsoft inched up about 0.25% to $488.32, Alphabet was up about 0.04% at $313.68, and Broadcom added about 0.53% to $351.23, while AMD slipped about 0.20% to $215.17.

The broader tape was subdued, with communication services outperforming as tech stocks churned, Reuters reported earlier. Trading volumes have stayed light into year-end, a setup that can exaggerate moves when a headline breaks.

Monday’s pullback snapped a six-session winning streak for heavyweight tech shares, even after the S&P 500 hit record highs last week, according to Reuters. Market participants have been watching whether AI-driven earnings growth can keep pace with valuations into 2026.

The next scheduled catalyst for the group is the Fed minutes release at 2 p.m. ET. The central bank’s quarter-point cut — 25 basis points, or 0.25 percentage point — took the policy rate range to 3.50%–3.75%, and the decision drew three dissents, Reuters reported.

Heading into the close, investors will be looking for whether Nvidia or Meta can extend gains on deal headlines, or whether thin liquidity keeps the AI complex pinned in narrow ranges. Any shift in the tone of the Fed minutes on inflation and labor-market risks could set the direction for AI-heavy portfolios into the final sessions of 2025.

Stock Market Today

  • Morgan Stanley Launches First Major Wall Street Spot Bitcoin ETF
    April 30, 2026, 11:57 AM EDT. Morgan Stanley debuted MSBT, its spot Bitcoin exchange-traded fund (ETF), marking the first from a major Wall Street bank. The ETF charges a 0.14% fee aimed at attracting institutional investors. Despite this, markets remain cautious; Bitcoin reaching $80,000 in April dropped from 26% to 17% YES on prediction markets the same day. This decline signals skepticism that the ETF alone will drive significant short-term price gains. Year-end Bitcoin price optimism remains modest at 5% YES, hampered by thin liquidity and broader concerns like regulatory and geopolitical challenges. Monitoring inflows into MSBT and rivals like BlackRock's IBIT will be crucial to gauge real institutional interest.

Latest article

Social Security’s $4 Million Question: Can the S&P 500 Beat a 2033 Benefits Cliff?

Social Security’s $4 Million Question: Can the S&P 500 Beat a 2033 Benefits Cliff?

30 April 2026
A retiree’s claim that Social Security payroll taxes could have grown to $4 million in the S&P 500 has renewed debate over the system’s structure. The Social Security Administration projects its main trust fund will be depleted by 2033, with incoming revenue covering 77% of benefits. The fund invests only in government securities, not stocks. The payroll tax rate is set at 12.4% of earnings up to $184,500 in 2026.
Everspin Technologies Stock Surges After $40 Million Defense MRAM Deal Puts Growth Back in View

Everspin Technologies Stock Surges After $40 Million Defense MRAM Deal Puts Growth Back in View

30 April 2026
FatPipe shares jumped 18% to $2.92 Thursday after the company announced expanded access to its SD-WAN and cybersecurity products through public-sector procurement channels. The move follows a VeloCloud replacement program targeting customers of Arista Networks’ SD-WAN business. Trading volume reached 42.2 million shares. Investors remain cautious over execution and customer concentration risks.
Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus
Previous Story

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook
Next Story

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Go toTop